Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2001

View Archived Issues

NC-381 shows potential inhibitory effects on prostate tumor growth in preclinical studies

Early data from NHL patients treated with CpG-7909 indicate good safety, immunostimulatory effects

Potential of CP-461 in CLL supported by laboratory research discussed at ASH meeting

Valrocemide characterized as a safe, broad-spectrum anticonvulsant agent

Mechanism of anticonvulsant action of CGX-1007, an NMDA antagonist, explored

Retigabine appears not to interfere with low-dose oral contraceptives

Zonegran effective and safe as monotherapy in partial seizures

Repifermin continues to show excellent safety profile in phase II trials for various indications

Amsterdam Molecular Therapeutics receives grant for LPL gene therapy

Excellent safety, evidence of activity for beta-alethine in immunocompetent lymphoma patients

First phase III trial of AC-2993 for type 2 diabetes under way

Synsorb discontinues Synsorb-Cd development program

Initiation of second phase I trial of Triapine in advanced leukemia

Endovasc submits revised phase III protocol for Liprostin; requests FDA meeting

Microbiotix obtains exclusive worldwide license to novel antiviral compounds

Notice of allowance of patent for once-daily Cidecin dosing regimen

Wide series of macrocyclic compounds for HCV designed and disclosed in recent patent

CXCR1/CXCR2 receptor antagonists in the GSK pipeline

Definity launched in North American markets for contrast enhancement in echocardiography

Inhibitors of VEGF receptor tyrosine kinase and their use described by AstraZeneca

New piperidines described in patent literature act as NK1 receptor antagonists

Somatostatin sst2 receptor antagonists synthesized at Pfizer elevate GH secretion

Novartis presents potent new PDE5 inhibitors for erectile dysfunction

Tyrosine kinase inhibitors useful in cancer Rx designed at Boehringer Ingelheim

CPMP recommends approval of Dynepo for anemia of renal failure

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...